Yeast Systematic Name | Yeast Symbol | SGDID | Analog Name | Analog Description | EC | Organism | Disease | Structure | Uniprot | Human ID | Human Symbol | HHsearch Probability | HHsearch E_value | HHsearch P_value | HHsearch Score | Flag Disease related | Flag Homo sapiens | Flag Mus musculus | Flag Danio rerio | Flag Drosophila melanogaster | Flag Caenorhabditis elegans | Flag Arabidopsis thaliana | Flag Escherichia coli |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
YJL168C | SET2 | SGDID:S000003704 | NSD1 ARA267 KMT3B |
Histone-lysine N-methyltransferase, H3 lysine-36 specific (EC 2.1.1.357) (Androgen receptor coactivator 267 kDa protein) (Androgen receptor-associated protein of 267 kDa) (H3-K36-HMTase) (Lysine N-methyltransferase 3B) (Nuclear receptor-binding SET domain-containing protein 1) (NR-binding SET domain-containing protein) |
2.1.1.357 | Homo sapiens | Heart Disease,Seizure Disorder,Kleefstra Syndrome,Pectus Carinatum,Deletion 5q35,Overgrowth Syndrome,Alpha Thalassemia-X-Linked Intellectual Disability Syndrome,Leukemia,5q35 Microduplication Syndrome,Cryptorchidism, Unilateral Or Bilateral,Leukemia, Acute Myeloid,Hereditary Spastic Paraplegia,Ganglioglioma,Spastic Paraplegia 8,Hyperinsulinemic Hypoglycemia,Wilms Tumor Predisposition,Myeloid Leukemia,Pre-Eclampsia,Patent Foramen Ovale,Marshall-Smith Syndrome,Farsightedness,Microcephaly,Weaver Syndrome,Sotos Syndrome 1,Alacrima, Achalasia, And Mental Retardation Syndrome,Cleft Palate, Isolated,Disease Of Mental Health,Kleefstra Syndrome 1,Alpha-Thalassemia,Developmental And Epileptic Encephalopathy 2,Beckwith-Wiedemann Syndrome,Lipedema,Cornelia De Lange Syndrome 5,Neuropathy, Hereditary Sensory, Type Ie,Myelodysplastic Syndrome,Preeclampsia/Eclampsia 1,Uvula, Bifid,Williams-Beuren Syndrome,Hypertelorism,Wolf-Hirschhorn Syndrome,Patent Ductus Arteriosus 1,Kabuki Syndrome 1,Scoliosis,Autosomal Dominant Non-Syndromic Intellectual Disability,Omphalocele,Macroglossia,Autism,Childhood Acute Myeloid Leukemia |
3ooi_a | Q96L73 | ENSG00000165671 | NSD1 | 100.00 | 4.10E-34 | 4.20E-38 | 282.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YJL168C | SET2 | SGDID:S000003704 | EZH2 |
EZH2 |
2.1.1.356 | Anolis carolinensis | 5ij7_a | G1KPH4 | 99.80 | 1.70E-23 | 1.50E-27 | 237.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YJL168C | SET2 | SGDID:S000003704 | KMT5B SUV420H1 CGI-85 |
Histone-lysine N-methyltransferase KMT5B (Lysine N-methyltransferase 5B) (Lysine-specific methyltransferase 5B) (Suppressor of variegation 4-20 homolog 1) (Su(var)4-20 homolog 1) (Suv4-20h1) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.361) |
2.1.1.361,2.1.1.362, | Homo sapiens | Primary Hyperoxaluria,Meier-Gorlin Syndrome 1,Mental Retardation, Autosomal Dominant 51,Autism Spectrum Disorder,Autism,Hyperoxaluria, Primary, Type I |
3s8p_a | Q4FZB7 | ENSG00000110066 | KMT5B | 99.60 | 1.30E-19 | 1.20E-23 | 184.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YJL168C | SET2 | SGDID:S000003704 | dim-5 29E8.110 NCU04402 |
Histone-lysine N-methyltransferase, H3 lysine-9 specific dim-5 (EC 2.1.1.355) (Histone H3-K9 methyltransferase dim-5) (H3-K9-HMTase dim-5) (HKMT) |
2.1.1.355 | Neurospora crassa | 1peg_a | Q8X225 | 99.90 | 1.20E-28 | 1.20E-32 | 252.10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YJL168C | SET2 | SGDID:S000003704 | SET1 SCY_2511 |
SET1 SCY_2511 |
2.1.1.354 | Saccharomyces cerevisiae | 6bx3_e | A6ZT27 | 99.70 | 1.20E-22 | 1.10E-26 | 208.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YJL168C | SET2 | SGDID:S000003704 | EZH2 KMT6 |
Histone-lysine N-methyltransferase EZH2 (EC 2.1.1.356) (ENX-1) (Enhancer of zeste homolog 2) (Lysine N-methyltransferase 6) |
2.1.1.356 | Homo sapiens | Skin Melanoma,Retinitis Pigmentosa,Cll/Sll,Chronic Myelomonocytic Leukemia,Melanoma,Breast Myoepithelial Carcinoma,Clear Cell Renal Cell Carcinoma,Diffuse Midline Glioma, H3 K27m-Mutant,B-Cell Lymphoma,Atypical Teratoid Rhabdoid Tumor,Essential Thrombocythemia,Posterior Fossa Ependymoma,Cholangiolocellular Carcinoma,Neuroblastoma,Primary Cutaneous Follicle Center Lymphoma,Leukemia, Acute Myeloid,Secondary Hemophagocytic Lymphohistiocytosis,Bone Marrow Cancer,Transitional Cell Carcinoma,Ezh2-Related Overgrowth,Bladder Cancer,Bile Duct Adenoma,Primary Hyperoxaluria,Ovarian Cancer,T-Cell Acute Lymphoblastic Leukemia,Breast Cancer,Colorectal Cancer,Hepatocellular Carcinoma,Malignant Peripheral Nerve Sheath Tumor,Rhabdomyosarcoma,Weaver Syndrome,Tongue Disease,Sotos Syndrome 1,Gastric Cancer,Breast Adenocarcinoma,Prostate Cancer,Disease Of Mental Health,Cholangiocarcinoma,Rhabdoid Cancer,Fragile X Syndrome,Lymphoma, Non-Hodgkin, Familial,Beckwith-Wiedemann Syndrome,Esophageal Cancer,Myelodysplastic Syndrome,Diffuse Large B-Cell Lymphoma,Ewing Sarcoma,Mantle Cell Lymphoma,Splenic Marginal Zone Lymphoma,Tongue Squamous Cell Carcinoma,Acute Promyelocytic Leukemia,Follicular Lymphoma,Ovarian Clear Cell Carcinoma,Nasopharyngeal Carcinoma,Lymphoma,Brain Glioma,Kabuki Syndrome 1,Juvenile Myelomonocytic Leukemia,Autosomal Dominant Non-Syndromic Intellectual Disability,Rett Syndrome,Myelofibrosis,Myeloma, Multiple,Medulloblastoma,Melanoma, Uveal,Childhood Acute Myeloid Leukemia,Lung Cancer,Hyperoxaluria, Primary, Type I,Pancreatic Cancer,Polycythemia Vera |
4mi5_a | Q15910 | ENSG00000106462 | EZH2 | 99.80 | 4.40E-24 | 4.40E-28 | 210.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YJL168C | SET2 | SGDID:S000003704 | ASH1L KIAA1420 KMT2H |
Histone-lysine N-methyltransferase ASH1L (EC 2.1.1.359) (EC 2.1.1.367) (ASH1-like protein) (huASH1) (Absent small and homeotic disks protein 1 homolog) (Lysine N-methyltransferase 2H) |
2.1.1.359 | Homo sapiens | Facioscapulohumeral Muscular Dystrophy 1,Sotos Syndrome 1,Pulpitis,Mental Retardation, Autosomal Dominant 52,Autism Spectrum Disorder,Autosomal Dominant Non-Syndromic Intellectual Disability,Autism |
4ynm_a | Q9NR48 | ENSG00000116539 | ASH1L | 99.90 | 2.30E-31 | 2.40E-35 | 261.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YJL168C | SET2 | SGDID:S000003704 | SUVH4 KYP SDG33 SET33 At5g13960 MAC12.7 |
Histone-lysine N-methyltransferase, H3 lysine-9 specific SUVH4 (EC 2.1.1.-) (Histone H3-K9 methyltransferase 4) (H3-K9-HMTase 4) (Protein KRYPTONITE) (Protein SET DOMAIN GROUP 33) (Suppressor of variegation 3-9 homolog protein 4) (Su(var)3-9 homolog protein 4) |
2.1.1.- | Arabidopsis thaliana | 4qeo_a | Q8GZB6 | 99.90 | 5.60E-28 | 5.40E-32 | 267.40 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |||
YJL168C | SET2 | SGDID:S000003704 | SET2 EZL1 KMT3 YJL168C J0520 |
Histone-lysine N-methyltransferase, H3 lysine-36 specific (EC 2.1.1.359) (Lysine N-methyltransferase 3) (SET domain-containing protein 2) |
2.1.1.359 | Saccharomyces cerevisiae | 2c5z_a | P46995 | 99.70 | 1.70E-21 | 1.40E-25 | 174.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YJL168C | SET2 | SGDID:S000003704 | SUV39H2 KMT1B |
Histone-lysine N-methyltransferase SUV39H2 (EC 2.1.1.355) (Histone H3-K9 methyltransferase 2) (H3-K9-HMTase 2) (Lysine N-methyltransferase 1B) (Suppressor of variegation 3-9 homolog 2) (Su(var)3-9 homolog 2) |
2.1.1.355 | Homo sapiens | Primary Hyperoxaluria,Carbohydrate Metabolic Disorder,Hyperoxaluria, Primary, Type I |
2r3a_a | Q9H5I1 | ENSG00000152455 | SUV39H2 | 99.90 | 1.30E-27 | 1.30E-31 | 246.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YJL168C | SET2 | SGDID:S000003704 | SET1 KLLA0F24134g |
Histone-lysine N-methyltransferase, H3 lysine-4 specific (EC 2.1.1.354) (COMPASS component SET1) (SET domain-containing protein 1) |
2.1.1.354 | Kluyveromyces lactis | 6chg_c | Q6CIT4 | 99.60 | 6.30E-21 | 7.00E-25 | 170.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YJL168C | SET2 | SGDID:S000003704 | SETD2 HIF1 HYPB KIAA1732 KMT3A SET2 HSPC069 |
Histone-lysine N-methyltransferase SETD2 (EC 2.1.1.359) (HIF-1) (Huntingtin yeast partner B) (Huntingtin-interacting protein 1) (HIP-1) (Huntingtin-interacting protein B) (Lysine N-methyltransferase 3A) (Protein-lysine N-methyltransferase SETD2) (EC 2.1.1.-) (SET domain-containing protein 2) (hSET2) (p231HBP) |
2.1.1.359 | Homo sapiens | Peritoneum Cancer,Lung Cancer Susceptibility 3,Collecting Duct Carcinoma,Clear Cell Renal Cell Carcinoma,Chromophobe Renal Cell Carcinoma,Corpus Callosum, Agenesis Of,Enteropathy-Associated T-Cell Lymphoma,Retinal Ischemia,Acute Leukemia,Leukemia, Acute Myeloid,Leukemia, Acute Lymphoblastic,Kidney Cancer,Dandy-Walker Syndrome,Acute Megakaryoblastic Leukemia Without Down Syndrome,Intellectual Disability - Hypoplastic Corpus Callosum - Preauricular Tag,Brain Cancer,Squamous Cell Carcinoma, Head And Neck,Colorectal Cancer,Age-Related Hearing Loss,Pheochromocytoma,Weaver Syndrome,Hepatosplenic T-Cell Lymphoma,Sotos Syndrome 1,Prostate Cancer,Renal Cell Carcinoma, Papillary, 1,Hydrocephalus, Congenital, 1,Renal Cell Carcinoma, Nonpapillary,Uterine Corpus Endometrial Carcinoma,Wolf-Hirschhorn Syndrome,Autism Spectrum Disorder,Luscan-Lumish Syndrome,Autism,Lung Cancer |
5jlb_a | Q9BYW2 | ENSG00000181555 | SETD2 | 99.90 | 3.60E-33 | 3.40E-37 | 286.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YJL168C | SET2 | SGDID:S000003704 | KMT2D ALR MLL2 MLL4 |
Histone-lysine N-methyltransferase 2D (Lysine N-methyltransferase 2D) (EC 2.1.1.354) (ALL1-related protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 2) |
2.1.1.354 | Homo sapiens | Charge Syndrome,Plasma Cell Neoplasm,Cold Agglutinin Disease,Kleefstra Syndrome,Cavernous Sinus Meningioma,Rasopathy,Holoprosencephaly,Hypoplastic Left Heart Syndrome,Leukemia, Acute Myeloid,Dandy-Walker Syndrome,Rubinstein Taybi Like Syndrome,Breast Malignant Phyllodes Tumor,Microphthalmia,Microcephaly,Weaver Syndrome,Sotos Syndrome 1,Alacrima, Achalasia, And Mental Retardation Syndrome,Fanconi Anemia, Complementation Group A,Disease Of Mental Health,Complement Component C1s Deficiency,Chromosome 16p13.3 Deletion Syndrome, Proximal,Mental Retardation, Autosomal Dominant 26,Childhood Medulloblastoma,Lung Squamous Cell Carcinoma,Smith-Magenis Syndrome,Spinocerebellar Ataxia 2,Tetralogy Of Fallot,Peripheral T-Cell Lymphoma,Congenital Disorder Of Glycosylation, Type Ig,Autism Spectrum Disorder,Lymphoma,Kabuki Syndrome 1,Kbg Syndrome,Methylmalonic Acidemia And Homocysteinemia, Cblx Type,Scoliosis,Autosomal Dominant Non-Syndromic Intellectual Disability,Myeloma, Multiple,Medulloblastoma,Isolated Growth Hormone Deficiency Type Iii,Postaxial Acrofacial Dysostosis |
4z4p_a | O14686 | ENSG00000167548 | KMT2D | 99.70 | 3.00E-22 | 3.20E-26 | 183.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YJL168C | SET2 | SGDID:S000003704 | SETMAR |
Histone-lysine N-methyltransferase SETMAR (SET domain and mariner transposase fusion protein) (Metnase) [Includes: Histone-lysine N-methyltransferase (EC 2.1.1.357); Transposon Hsmar1 transposase (EC 3.1.-.-)] |
2.1.1.357 | Homo sapiens | Meier-Gorlin Syndrome 1,Fanconi Anemia, Complementation Group A |
3bo5_a | Q53H47 | ENSG00000170364 | SETMAR | 99.90 | 9.50E-29 | 9.50E-33 | 252.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YJL168C | SET2 | SGDID:S000003704 | EHMT2 BAT8 C6orf30 G9A KMT1C NG36 |
Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) |
2.1.1.- | Homo sapiens | Kleefstra Syndrome,Choline Deficiency Disease,Brain Cancer,Cockayne Syndrome,Primary Hyperoxaluria,Carbohydrate Metabolic Disorder,Prader-Willi Syndrome,Disease Of Mental Health,Kleefstra Syndrome 1,Basan Syndrome,Hyperoxaluria, Primary, Type I |
5tuy_a | Q96KQ7 | ENSG00000204371 | EHMT2 | 99.90 | 6.00E-29 | 6.00E-33 | 251.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YJL168C | SET2 | SGDID:S000003704 | CTHT_0006210 |
CTHT_0006210 |
Chaetomium thermophilum | 5kkl_b | G0RYC6 | ENSG00000275714 | H3C1 | 99.70 | 5.70E-23 | 5.00E-27 | 241.10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
YJL168C | SET2 | SGDID:S000003704 | Kmt5b Suv420h1 |
Histone-lysine N-methyltransferase KMT5B (Lysine-specific methyltransferase 5B) (Suppressor of variegation 4-20 homolog 1) (Su(var)4-20 homolog 1) (Suv4-20h1) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.361) |
2.1.1.361,2.1.1.362, | Mus musculus | 4bup_b | Q3U8K7 | 99.60 | 9.90E-20 | 9.60E-24 | 184.70 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||
YJL168C | SET2 | SGDID:S000003704 | SUVH9 SDG22 SET22 At4g13460 T6G15.10 |
Histone-lysine N-methyltransferase family member SUVH9 (Histone H3-K9 methyltransferase 9) (H3-K9-HMTase 9) (Protein SET DOMAIN GROUP 22) (Suppressor of variegation 3-9 homolog protein 9) (Su(var)3-9 homolog protein 9) |
Arabidopsis thaliana | 4nj5_a | Q9T0G7 | 99.80 | 6.60E-26 | 6.30E-30 | 250.40 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | ||||
YJL168C | SET2 | SGDID:S000003704 | SUVH6 SDG23 SET23 At2g22740 T9I22.18 |
Histone-lysine N-methyltransferase, H3 lysine-9 specific SUVH6 (EC 2.1.1.-) (Histone H3-K9 methyltransferase 6) (H3-K9-HMTase 6) (Protein SET DOMAIN GROUP 23) (Suppressor of variegation 3-9 homolog protein 6) (Su(var)3-9 homolog protein 6) |
2.1.1.- | Arabidopsis thaliana | 6a5k_a | Q8VZ17 | 99.90 | 7.20E-28 | 7.00E-32 | 265.70 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |||
YJL168C | SET2 | SGDID:S000003704 | SRI |
SRI (Set2 Rpb1 interacting) domain |
pfam Domain | PF08236 | 99.50 | 3.70E-19 | 3.30E-23 | 152.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
YJL168C | SET2 | SGDID:S000003704 | KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 |
Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.354) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] |
2.1.1.354 | Homo sapiens | Childhood Acute Lymphocytic Leukemia,Lymphoblastic Lymphoma,Hypertrichosis,Chronic Neutrophilic Leukemia,Chronic Myelomonocytic Leukemia,Cornelia De Lange Syndrome,Leukemia, Chronic Myeloid,Acute Myeloid Leukemia With T(9;11)(P22;Q23),B-Lymphoblastic Leukemia/Lymphoma,B-Lymphoblastic Leukemia/Lymphoma With Bcr-Abl1,B-Lymphoblastic Leukemia/Lymphoma With Iamp21,Rare Genetic Intellectual Disability,Myeloproliferative Neoplasm,Leukemia,Pancytopenia,Mixed Phenotype Acute Leukemia,Childhood Leukemia,Acute Leukemia,Leukemia, Acute Myeloid,Acute Myeloid Leukemia With 11q23 Abnormalities,Intravascular Large B-Cell Lymphoma,Familial Isolated Trichomegaly,Myelodysplastic/Myeloproliferative Neoplasm,Hematologic Cancer,Leukemia, Acute Lymphoblastic,Ring Chromosome 21,Acute Megakaryoblastic Leukemia Without Down Syndrome,Rubinstein Taybi Like Syndrome,Central Nervous System Leukemia,Monocytic Leukemia,Ring Chromosome,Myeloid Sarcoma,Myeloid Leukemia,Acute Megakaryocytic Leukemia,Acute Monoblastic Leukemia,Colon Leiomyoma,Cytogenetically Normal Acute Myeloid Leukemia,Microcephaly,Hypoxia,Chronic Granulomatous Disease,Alacrima, Achalasia, And Mental Retardation Syndrome,Leukemia, Acute Lymphoblastic 3,Disease Of Mental Health,Cornelia De Lange Syndrome 1,Lymphoma, Non-Hodgkin, Familial,Wiedemann-Steiner Syndrome,Myelodysplastic Syndrome,Hairy Elbows,Acute Promyelocytic Leukemia,Wilms Tumor 1,Kabuki Syndrome 1,Kbg Syndrome,Leukemia, Acute Monocytic,Leukemia, Chronic Lymphocytic,Juvenile Myelomonocytic Leukemia,Autosomal Dominant Non-Syndromic Intellectual Disability,Autism |
5f5e_a | Q03164 | ENSG00000118058 | KMT2A | 99.70 | 3.80E-21 | 4.20E-25 | 173.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YJL168C | SET2 | SGDID:S000003704 | EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D |
Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D) |
2.1.1.- | Homo sapiens | Kleefstra Syndrome,Deafness, Autosomal Dominant 47,Hypoplastic Left Heart Syndrome,Polymicrogyria,Kleefstra Syndrome Due To A Point Mutation,Pontocerebellar Hypoplasia, Type 2a,Weaver Syndrome,Sotos Syndrome 1,Alacrima, Achalasia, And Mental Retardation Syndrome,Disease Of Mental Health,Kleefstra Syndrome 1,Chromosome 16p13.3 Deletion Syndrome, Proximal,Pitt-Hopkins Syndrome,Schizophrenia,Ogden Syndrome,Autism Spectrum Disorder,Kabuki Syndrome 1,Autosomal Dominant Non-Syndromic Intellectual Disability,Chromosomal Deletion Syndrome,Autism,Christianson Syndrome |
5vsf_a | Q9H9B1 | ENSG00000181090 | EHMT1 | 99.90 | 1.70E-28 | 1.70E-32 | 246.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YJL168C | SET2 | SGDID:S000003704 | KMT5C SUV420H2 PP7130 |
Histone-lysine N-methyltransferase KMT5C (Lysine N-methyltransferase 5C) (Lysine-specific methyltransferase 5C) (Suppressor of variegation 4-20 homolog 2) (Su(var)4-20 homolog 2) (Suv4-20h2) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.361) |
2.1.1.361,2.1.1.362, | Homo sapiens | Primary Hyperoxaluria,Hyperoxaluria, Primary, Type I |
3rq4_a | Q86Y97 | ENSG00000133247 | KMT5C | 99.60 | 5.50E-20 | 5.50E-24 | 182.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YJL168C | SET2 | SGDID:S000003704 | NSD3 WHSC1L1 DC28 |
Histone-lysine N-methyltransferase NSD3 (EC 2.1.1.370) (EC 2.1.1.371) (Nuclear SET domain-containing protein 3) (Protein whistle) (WHSC1-like 1 isoform 9 with methyltransferase activity to lysine) (Wolf-Hirschhorn syndrome candidate 1-like protein 1) (WHSC1-like protein 1) |
2.1.1.370,2.1.1.371, | Homo sapiens | Weaver Syndrome,Sotos Syndrome 1,Kleefstra Syndrome 1,Wolf-Hirschhorn Syndrome,Nut Midline Carcinoma,Childhood Acute Myeloid Leukemia |
6cen_a | Q9BZ95 | ENSG00000147548 | NSD3 | 99.90 | 1.90E-33 | 2.00E-37 | 276.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YJL168C | SET2 | SGDID:S000003704 | clr4 kmt1 SPBC428.08c |
Histone-lysine N-methyltransferase, H3 lysine-9 specific (EC 2.1.1.355) (Cryptic loci regulator 4) (Histone H3-K9 methyltransferase) (H3-K9-HMTase) (HKMT) (Lysine N-methyltransferase 1) (Protein lysine methyltransferase clr4) (PKMT) |
2.1.1.355 | Schizosaccharomyces pombe | 6bp4_b | O60016 | 99.90 | 2.50E-28 | 2.50E-32 | 251.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YJL168C | SET2 | SGDID:S000003704 | cgd4_370 |
cgd4_370 |
Cryptosporidium parvum | 4ldg_a | Q5CQK4 | 99.60 | 2.10E-19 | 1.90E-23 | 184.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |